SEMA3D and Alzheimer disease: Among the three AD datasets, hippocampal Sema3D levels were significantly higher in the subjects with more severe AD in two datasets (GSE1297 and GSE48350) (Table 1) while also being higher in subjects with more severe clinical dementia (GSE84422) and FTLD-U (GSE13162) (Table 1).